APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

HGH Biosimilars

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HGH Biosimilars Industry Growth and Trends Forecast to 2032

Report ID 173998400122 December 2025107 pages

Choose your research edition.

Industry ResearchHGH Biosimilars Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal HGH Biosimilars Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal HGH Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HGH Biosimilars Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal HGH Biosimilars Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global HGH Biosimilars market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HGH Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HGH Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HGH Biosimilars is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HGH Biosimilars include Teva Pharmaceutical, Sun Pharmaceutical, Johnson & Johnson, Novartis, Sigma-Tau Group, Pacira, Luye Pharma, Kingond Pharm and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HGH Biosimilars market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HGH Biosimilars market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HGH Biosimilars market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HGH Biosimilars.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HGH Biosimilars market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HGH Biosimilars Market by Company

Teva Pharmaceutical

Sun Pharmaceutical

Johnson & Johnson

Novartis

Sigma-Tau Group

Pacira

Luye Pharma

Kingond Pharm

Gilead Sciences

Fudan-Zhangjiang

CSPC

HGH Biosimilars Segment by Type

Clinical

Experiment

HGH Biosimilars Segment by Application

Treament

Prevention

HGH Biosimilars Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HGH Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HGH Biosimilars and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HGH Biosimilars.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HGH Biosimilars manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HGH Biosimilars in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Clinical Table 2. Major Company of Experiment Table 3. Global HGH Biosimilars Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global HGH Biosimilars Sales by Type (2021-2026) & (k units) Table 5. Global HGH Biosimilars Sales Market Share in Volume by Type (2021-2026) Table 6. Global HGH Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 7. Global HGH Biosimilars Sales Market Share in Value by Type (2021-2026) Table 8. Global HGH Biosimilars Price by Type (2021-2026) & (US$/unit) Table 9. Global HGH Biosimilars Sales by Type (2027-2032) & (k units) Table 10. Global HGH Biosimilars Sales Market Share in Volume by Type (2027-2032) Table 11. Global HGH Biosimilars Sales by Type (2027-2032) & (US$ Million) Table 12. Global HGH Biosimilars Sales Market Share in Value by Type (2027-2032) Table 13. Global HGH Biosimilars Price by Type (2027-2032) & (US$/unit) Table 14. North America HGH Biosimilars Sales by Type (2021-2026) & (k units) Table 15. North America HGH Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 16. Europe HGH Biosimilars Sales by Type (2021-2026) & (k units) Table 17. Europe HGH Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific HGH Biosimilars Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific HGH Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America HGH Biosimilars Sales by Type (2021-2026) & (k units) Table 21. Latin America HGH Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa HGH Biosimilars Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa HGH Biosimilars Sales by Type (2021-2026) & (US$ Million) Table 24. HGH Biosimilars Industry Trends Table 25. HGH Biosimilars Industry Drivers Table 26. HGH Biosimilars Industry Opportunities and Challenges Table 27. HGH Biosimilars Industry Restraints Table 28. Global HGH Biosimilars Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global HGH Biosimilars Revenue Market Share by Company (2021-2026) Table 30. Global HGH Biosimilars Sales by Company (2021-2026) & (k units) Table 31. Global HGH Biosimilars Sales Share by Company (2021-2026) Table 32. Global HGH Biosimilars Market Price by Company (2021-2026) & (US$/unit) Table 33. Global HGH Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global HGH Biosimilars Major Company Production Sites and Headquarters Table 35. Global HGH Biosimilars Company, Product Type & Application Table 36. Global HGH Biosimilars Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global HGH Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global HGH Biosimilars Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global HGH Biosimilars Sales by Region (2021-2026) & (k units) Table 41. Global HGH Biosimilars Sales Market Share in Volume by Region (2021-2026) Table 42. Global HGH Biosimilars Sales by Region (2021-2026) & (US$ Million) Table 43. Global HGH Biosimilars Sales Market Share in Value by Region (2021-2026) Table 44. Global HGH Biosimilars Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global HGH Biosimilars Sales by Region (2027-2032) & (k units) Table 46. Global HGH Biosimilars Sales Market Share in Volume by Region (2027-2032) Table 47. Global HGH Biosimilars Sales by Region (2027-2032) & (US$ Million) Table 48. Global HGH Biosimilars Sales Market Share in Value by Region (2027-2032) Table 49. Global HGH Biosimilars Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global HGH Biosimilars Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global HGH Biosimilars Sales by Application (2021-2026) & (k units) Table 52. Global HGH Biosimilars Sales Market Share in Volume by Application (2021-2026) Table 53. Global HGH Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 54. Global HGH Biosimilars Sales Market Share in Value by Application (2021-2026) Table 55. Global HGH Biosimilars Price by Application (2021-2026) & (US$/unit) Table 56. Global HGH Biosimilars Sales by Application (2027-2032) & (k units) Table 57. Global HGH Biosimilars Sales Market Share in Volume by Application (2027-2032) Table 58. Global HGH Biosimilars Sales by Application (2027-2032) & (US$ Million) Table 59. Global HGH Biosimilars Sales Market Share in Value by Application (2027-2032) Table 60. Global HGH Biosimilars Price by Application (2027-2032) & (US$/unit) Table 61. North America HGH Biosimilars Sales by Application (2021-2026) & (k units) Table 62. North America HGH Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 63. Europe HGH Biosimilars Sales by Application (2021-2026) & (k units) Table 64. Europe HGH Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific HGH Biosimilars Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific HGH Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America HGH Biosimilars Sales by Application (2021-2026) & (k units) Table 68. Latin America HGH Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa HGH Biosimilars Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa HGH Biosimilars Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Company Information Table 72. Teva Pharmaceutical Business Overview Table 73. Teva Pharmaceutical HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical HGH Biosimilars Product Portfolio Table 75. Teva Pharmaceutical Recent Development Table 76. Sun Pharmaceutical Company Information Table 77. Sun Pharmaceutical Business Overview Table 78. Sun Pharmaceutical HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical HGH Biosimilars Product Portfolio Table 80. Sun Pharmaceutical Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Johnson & Johnson HGH Biosimilars Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novartis HGH Biosimilars Product Portfolio Table 90. Novartis Recent Development Table 91. Sigma-Tau Group Company Information Table 92. Sigma-Tau Group Business Overview Table 93. Sigma-Tau Group HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sigma-Tau Group HGH Biosimilars Product Portfolio Table 95. Sigma-Tau Group Recent Development Table 96. Pacira Company Information Table 97. Pacira Business Overview Table 98. Pacira HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Pacira HGH Biosimilars Product Portfolio Table 100. Pacira Recent Development Table 101. Luye Pharma Company Information Table 102. Luye Pharma Business Overview Table 103. Luye Pharma HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Luye Pharma HGH Biosimilars Product Portfolio Table 105. Luye Pharma Recent Development Table 106. Kingond Pharm Company Information Table 107. Kingond Pharm Business Overview Table 108. Kingond Pharm HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kingond Pharm HGH Biosimilars Product Portfolio Table 110. Kingond Pharm Recent Development Table 111. Gilead Sciences Company Information Table 112. Gilead Sciences Business Overview Table 113. Gilead Sciences HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Gilead Sciences HGH Biosimilars Product Portfolio Table 115. Gilead Sciences Recent Development Table 116. Fudan-Zhangjiang Company Information Table 117. Fudan-Zhangjiang Business Overview Table 118. Fudan-Zhangjiang HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Fudan-Zhangjiang HGH Biosimilars Product Portfolio Table 120. Fudan-Zhangjiang Recent Development Table 121. CSPC Company Information Table 122. CSPC Business Overview Table 123. CSPC HGH Biosimilars Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. CSPC HGH Biosimilars Product Portfolio Table 125. CSPC Recent Development Table 126. North America HGH Biosimilars Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America HGH Biosimilars Sales by Country (2021-2026) & (k units) Table 128. North America HGH Biosimilars Sales Market Share by Country (2021-2026) Table 129. North America HGH Biosimilars Sales Forecast by Country (2027-2032) & (k units) Table 130. North America HGH Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 131. North America HGH Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America HGH Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 133. North America HGH Biosimilars Market Share by Country (2021-2026) Table 134. North America HGH Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America HGH Biosimilars Market Share Forecast by Country (2027-2032) Table 136. Europe HGH Biosimilars Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe HGH Biosimilars Sales by Country (2021-2026) & (k units) Table 138. Europe HGH Biosimilars Sales Market Share by Country (2021-2026) Table 139. Europe HGH Biosimilars Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe HGH Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 141. Europe HGH Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe HGH Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe HGH Biosimilars Market Share by Country (2021-2026) Table 144. Europe HGH Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe HGH Biosimilars Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific HGH Biosimilars Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific HGH Biosimilars Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific HGH Biosimilars Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific HGH Biosimilars Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific HGH Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific HGH Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific HGH Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific HGH Biosimilars Market Share by Country (2021-2026) Table 154. Asia-Pacific HGH Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific HGH Biosimilars Market Share Forecast by Country (2027-2032) Table 156. Latin America HGH Biosimilars Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America HGH Biosimilars Sales by Country (2021-2026) & (k units) Table 158. Latin America HGH Biosimilars Sales Market Share by Country (2021-2026) Table 159. Latin America HGH Biosimilars Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America HGH Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America HGH Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America HGH Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America HGH Biosimilars Market Share by Country (2021-2026) Table 164. Latin America HGH Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America HGH Biosimilars Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa HGH Biosimilars Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa HGH Biosimilars Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa HGH Biosimilars Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa HGH Biosimilars Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa HGH Biosimilars Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa HGH Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa HGH Biosimilars Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa HGH Biosimilars Market Share by Country (2021-2026) Table 174. Middle East and Africa HGH Biosimilars Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa HGH Biosimilars Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. HGH Biosimilars Distributors List Table 179. HGH Biosimilars Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. HGH Biosimilars Image Figure 2. Global HGH Biosimilars Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HGH Biosimilars Market Size (2021-2032) & (US$ Million) Figure 4. Global HGH Biosimilars Sales (2021-2032) & (k units) Figure 5. Clinical Image Figure 6. Global Clinical Sales YoY Growth (2021-2032) & (k units) Figure 7. Experiment Image Figure 8. Global Experiment Sales YoY Growth (2021-2032) & (k units) Figure 9. Global HGH Biosimilars Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global HGH Biosimilars Market Share by Type 2025 VS 2032 Figure 11. North America HGH Biosimilars Sales Market Share in Volume by Type in 2025 Figure 12. North America HGH Biosimilars Sales Market Share in Value by Type in 2025 Figure 13. Europe HGH Biosimilars Sales Market Share in Volume by Type in 2025 Figure 14. Europe HGH Biosimilars Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific HGH Biosimilars Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific HGH Biosimilars Sales Market Share in Value by Type in 2025 Figure 17. Latin America HGH Biosimilars Sales Market Share in Volume by Type in 2025 Figure 18. Latin America HGH Biosimilars Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa HGH Biosimilars Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa HGH Biosimilars Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 HGH Biosimilars Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Treament Image Figure 24. Global Treament Sales YoY Growth (2021-2032) & (k units) Figure 25. Prevention Image Figure 26. Global Prevention Sales YoY Growth (2021-2032) & (k units) Figure 27. Global HGH Biosimilars Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global HGH Biosimilars Market Share by Application 2025 VS 2032 Figure 29. North America HGH Biosimilars Sales Market Share in Volume by Application in 2025 Figure 30. North America HGH Biosimilars Sales Market Share in Value by Application in 2025 Figure 31. Europe HGH Biosimilars Sales Market Share in Volume by Application in 2025 Figure 32. Europe HGH Biosimilars Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific HGH Biosimilars Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific HGH Biosimilars Sales Market Share in Value by Application in 2025 Figure 35. Latin America HGH Biosimilars Sales Market Share in Volume by Application in 2025 Figure 36. Latin America HGH Biosimilars Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa HGH Biosimilars Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa HGH Biosimilars Sales Market Share in Value by Application in 2025 Figure 39. North America HGH Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America HGH Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America HGH Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America HGH Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe HGH Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe HGH Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe HGH Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe HGH Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific HGH Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific HGH Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific HGH Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific HGH Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America HGH Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America HGH Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America HGH Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America HGH Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa HGH Biosimilars Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa HGH Biosimilars Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa HGH Biosimilars Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa HGH Biosimilars Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. HGH Biosimilars Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. HGH Biosimilars Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical
  • Experiment
Applications
  • Treament
  • Prevention
Companies covered
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • Sigma-Tau Group
  • Pacira
  • Luye Pharma
  • Kingond Pharm
  • Gilead Sciences
  • Fudan-Zhangjiang
  • CSPC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HGH Biosimilars Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HGH Biosimilars Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HGH Biosimilars Market by Type
  6. 1.3.1 Clinical
  7. 1.3.2 Experiment
  8. 1.4 Global HGH Biosimilars Market Size by Type
  9. 1.4.1 Global HGH Biosimilars Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global HGH Biosimilars Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global HGH Biosimilars Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America HGH Biosimilars Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe HGH Biosimilars Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific HGH Biosimilars Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America HGH Biosimilars Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa HGH Biosimilars Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HGH Biosimilars Industry Trends
  2. 2.2 HGH Biosimilars Industry Drivers
  3. 2.3 HGH Biosimilars Industry Opportunities and Challenges
  4. 2.4 HGH Biosimilars Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HGH Biosimilars Revenue (2021-2026)
  2. 3.2 Global Top Players by HGH Biosimilars Sales (2021-2026)
  3. 3.3 Global Top Players by HGH Biosimilars Price (2021-2026)
  4. 3.4 Global HGH Biosimilars Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HGH Biosimilars Major Company Production Sites & Headquarters
  6. 3.6 Global HGH Biosimilars Company, Product Type & Application
  7. 3.7 Global HGH Biosimilars Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HGH Biosimilars Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HGH Biosimilars Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HGH Biosimilars Tier 1, Tier 2, and Tier 3
4 HGH Biosimilars Regional Status and Outlook
  1. 4.1 Global HGH Biosimilars Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HGH Biosimilars Historic Market Size by Region
  3. 4.2.1 Global HGH Biosimilars Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HGH Biosimilars Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HGH Biosimilars Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HGH Biosimilars Forecasted Market Size by Region
  7. 4.3.1 Global HGH Biosimilars Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HGH Biosimilars Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HGH Biosimilars Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HGH Biosimilars by Application
  1. 5.1 HGH Biosimilars Market by Application
  2. 5.1.1 Treament
  3. 5.1.2 Prevention
  4. 5.2 Global HGH Biosimilars Market Size by Application
  5. 5.2.1 Global HGH Biosimilars Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global HGH Biosimilars Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global HGH Biosimilars Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America HGH Biosimilars Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe HGH Biosimilars Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific HGH Biosimilars Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America HGH Biosimilars Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa HGH Biosimilars Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical HGH Biosimilars Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical HGH Biosimilars Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson HGH Biosimilars Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis HGH Biosimilars Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Sigma-Tau Group
  26. 6.5.1 Sigma-Tau Group Company Information
  27. 6.5.2 Sigma-Tau Group Business Overview
  28. 6.5.3 Sigma-Tau Group HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sigma-Tau Group HGH Biosimilars Product Portfolio
  30. 6.5.5 Sigma-Tau Group Recent Developments
  31. 6.6 Pacira
  32. 6.6.1 Pacira Company Information
  33. 6.6.2 Pacira Business Overview
  34. 6.6.3 Pacira HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pacira HGH Biosimilars Product Portfolio
  36. 6.6.5 Pacira Recent Developments
  37. 6.7 Luye Pharma
  38. 6.7.1 Luye Pharma Company Information
  39. 6.7.2 Luye Pharma Business Overview
  40. 6.7.3 Luye Pharma HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Luye Pharma HGH Biosimilars Product Portfolio
  42. 6.7.5 Luye Pharma Recent Developments
  43. 6.8 Kingond Pharm
  44. 6.8.1 Kingond Pharm Company Information
  45. 6.8.2 Kingond Pharm Business Overview
  46. 6.8.3 Kingond Pharm HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kingond Pharm HGH Biosimilars Product Portfolio
  48. 6.8.5 Kingond Pharm Recent Developments
  49. 6.9 Gilead Sciences
  50. 6.9.1 Gilead Sciences Company Information
  51. 6.9.2 Gilead Sciences Business Overview
  52. 6.9.3 Gilead Sciences HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Gilead Sciences HGH Biosimilars Product Portfolio
  54. 6.9.5 Gilead Sciences Recent Developments
  55. 6.10 Fudan-Zhangjiang
  56. 6.10.1 Fudan-Zhangjiang Company Information
  57. 6.10.2 Fudan-Zhangjiang Business Overview
  58. 6.10.3 Fudan-Zhangjiang HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Fudan-Zhangjiang HGH Biosimilars Product Portfolio
  60. 6.10.5 Fudan-Zhangjiang Recent Developments
  61. 6.11 CSPC
  62. 6.11.1 CSPC Company Information
  63. 6.11.2 CSPC Business Overview
  64. 6.11.3 CSPC HGH Biosimilars Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CSPC HGH Biosimilars Product Portfolio
  66. 6.11.5 CSPC Recent Developments
7 North America by Country
  1. 7.1 North America HGH Biosimilars Sales by Country
  2. 7.1.1 North America HGH Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HGH Biosimilars Sales by Country (2021-2026)
  4. 7.1.3 North America HGH Biosimilars Sales Forecast by Country (2027-2032)
  5. 7.2 North America HGH Biosimilars Market Size by Country
  6. 7.2.1 North America HGH Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HGH Biosimilars Market Size by Country (2021-2026)
  8. 7.2.3 North America HGH Biosimilars Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HGH Biosimilars Sales by Country
  2. 8.1.1 Europe HGH Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HGH Biosimilars Sales by Country (2021-2026)
  4. 8.1.3 Europe HGH Biosimilars Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HGH Biosimilars Market Size by Country
  6. 8.2.1 Europe HGH Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HGH Biosimilars Market Size by Country (2021-2026)
  8. 8.2.3 Europe HGH Biosimilars Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HGH Biosimilars Sales by Country
  2. 9.1.1 Asia-Pacific HGH Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HGH Biosimilars Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HGH Biosimilars Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HGH Biosimilars Market Size by Country
  6. 9.2.1 Asia-Pacific HGH Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HGH Biosimilars Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HGH Biosimilars Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HGH Biosimilars Sales by Country
  2. 10.1.1 South America HGH Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HGH Biosimilars Sales by Country (2021-2026)
  4. 10.1.3 South America HGH Biosimilars Sales Forecast by Country (2027-2032)
  5. 10.2 South America HGH Biosimilars Market Size by Country
  6. 10.2.1 South America HGH Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HGH Biosimilars Market Size by Country (2021-2026)
  8. 10.2.3 South America HGH Biosimilars Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HGH Biosimilars Sales by Country
  2. 11.1.1 Middle East and Africa HGH Biosimilars Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HGH Biosimilars Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HGH Biosimilars Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HGH Biosimilars Market Size by Country
  6. 11.2.1 Middle East and Africa HGH Biosimilars Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HGH Biosimilars Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HGH Biosimilars Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HGH Biosimilars Value Chain Analysis
  2. 12.1.1 HGH Biosimilars Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HGH Biosimilars Production Mode & Process
  7. 12.2 HGH Biosimilars Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HGH Biosimilars Distributors
  10. 12.2.3 HGH Biosimilars Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst